BA
SCLN

BlackRock Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

BlackRock Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.77M Sell
348,599
-28,958
-8% -$290K ﹤0.01% 1243
2016
Q3 		$3.87M Sell
377,557
-449
-0.1% -$4.89K ﹤0.01% 1208
2016
Q2 		$4.94M Sell
378,006
-185,597
-33% -$2.43M 0.01% 1114
2016
Q1 		$6.2M Sell
563,603
-175,022
-24% -$1.56M 0.01% 1007
2015
Q4 		$6.79M Sell
738,625
-18,636
-2% -$156K 0.01% 1005
2015
Q3 		$5.25M Sell
757,261
-7,905
-1% -$67.7K 0.01% 1073
2015
Q2 		$7.51M Buy
765,166
+510,282
+200% +$4.65M 0.01% 852
2015
Q1 		$2.26M Buy
254,884
+10,974
+4% +$87.4K ﹤0.01% 1182
2014
Q4 		$2.14M Sell
243,910
-44,711
-15% -$362K ﹤0.01% 1182
2014
Q3 		$1.99M Sell
288,621
-89,466
-24% -$536K ﹤0.01% 1178
2014
Q2 		$1.99M Sell
378,087
-254,936
-40% -$1.24M ﹤0.01% 1181
2014
Q1 		$2.88M Buy
633,023
+4,052
+0.6% +$19.6K ﹤0.01% 1087
2013
Q4 		$3.17M Sell
628,971
-8,458
-1% -$40.7K ﹤0.01% 1072
2013
Q3 		$3.23M Buy
637,429
+362,742
+132% +$2.02M ﹤0.01% 1067
2013
Q2 		$1.36M Buy
+274,687
New +$1.31M ﹤0.01% 1250

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BlackRock Advisors's SCLN Position: Q4 2016 in Review

BlackRock Advisors reduced its Sciclone Pharmaceuticals Inc (SCLN) stake by 7.7% in Q4 2016, selling an estimated $290K and leaving 348,599 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

BlackRock Advisors first reported a position in SCLN in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.51M in Q2 2015. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • BlackRock Advisors held 348,599 shares of Sciclone Pharmaceuticals Inc worth $3.77M as of Q4 2016.
  • BlackRock Advisors sold 28,958 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $290K.
  • Sciclone Pharmaceuticals Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1243 holding.
  • BlackRock Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Sciclone Pharmaceuticals Inc position peaked at $7.51M in Q2 2015.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.